Loading chat...

TX SB241

Bill

Status

Passed

5/27/2023

Primary Sponsor

Charles Perry

Click for details

Origin

Senate

88th Legislature Regular Session

AI Summary

Legislative Description

Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

Health

Last Action

Effective on . . . . . . . . . . . . . . . September 1, 2024

5/27/2023

Committee Referrals

Public Health4/10/2023
Health & Human Services2/15/2023

Full Bill Text

No bill text available